FDA Approves First Disease-Modifying Drug for Rare Anemia
The FDA has approved Agios Pharmaceuticals' Pyrukynd for a rare type of hemolytic anemia.
Jackie Fouse European Medicines Agency Drug Administration Patient Assistance Program Agios Pharmaceutical Agio Phase
Source: biospace.com